Regulatory Challenges in Cosmeceuticals: The need for Comprehensive Harmonized Guidelines

Clicks: 7
ID: 309159
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #21 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Cosmeceuticals, which is considered at the intersection of cosmetics and pharmaceuticals, have experienced significant growth worldwide in recent years. These products are formulated with biologically active ingredients that offer both aesthetic and therapeutic benefits, including anti-aging properties, pigmentation control, acne treatment, and skin rejuvenation. However, despite their increasing popularity, regulatory oversight of cosmeceuticals remains inconsistent and unclear in various regions. Unlike pharmaceuticals, cosmeceuticals are often marketed without rigorous clinical trials or regulatory assessments, even when they make functional or therapeutic claims. This regulatory ambiguity presents challenges in terms of consumer safety, product effectiveness, quality control, and accurate labeling. In many countries, cosmeceuticals are still regulated as general cosmetics, resulting in minimal scrutiny of the bioactive ingredients they contain. This has led to potential health risks, misleading advertising, product contamination, and a lack of standardized testing procedures. As a result, the credibility of the cosmeceutical industry is at stake, particularly in the absence of a unified global regulatory framework. This review aims to examine the current regulatory approaches in major markets such as the United States, European Union, India, Japan, China, and Canada, while exploring the discrepancies between these regions. Furthermore, the article emphasizes the need for stricter quality control measures, the importance of scientifically supported claims, and the incorporation of ethical considerations and new research into future regulations. Establishing an internationally accepted regulatory framework will enhance transparency, safeguard consumers, and encourage innovation in the cosmeceutical industry, ultimately benefiting both public health and the industry's reputation.
Reference Key
imported_1761926415_6904dd0f4d5a6 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Maanvi Sharma, Sungtina Jamir
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2025
DOI
10.62896/ijpdd.2.5.04
URL
https://ijpdd.org/index.php/files/article/view/270
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.